Tourniquet on the low segment of the uterus reduces blood loss in postpartum hemorrhage during hysterectomy for placenta accreta: Old but gold

Objectives: To investigate the feasibility, safety, and efficiency after application of a cervical tourniquet during caesarian hysterectomy owing to placenta accreta Study design: It was a monocentric prospective observational study for 3 years. Patients were allocated into two group: Group Tourniqu...

Full description

Saved in:
Bibliographic Details
Main Authors: Hassine S. Abouda (Author), Sofiene B. Marzouk (Author), Yecer Boussarsar (Author), Haithem Aloui (Author), Hatem Frikha (Author), Rami Hammami (Author), Badis Chennoufi (Author), Hayen Maghrebi (Author)
Format: Book
Published: Elsevier, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ba86016bc2bd41ed8f65cf3d71b22de4
042 |a dc 
100 1 0 |a Hassine S. Abouda  |e author 
700 1 0 |a Sofiene B. Marzouk  |e author 
700 1 0 |a Yecer Boussarsar  |e author 
700 1 0 |a Haithem Aloui  |e author 
700 1 0 |a Hatem Frikha  |e author 
700 1 0 |a Rami Hammami  |e author 
700 1 0 |a Badis Chennoufi  |e author 
700 1 0 |a Hayen Maghrebi  |e author 
245 0 0 |a Tourniquet on the low segment of the uterus reduces blood loss in postpartum hemorrhage during hysterectomy for placenta accreta: Old but gold 
260 |b Elsevier,   |c 2024-03-01T00:00:00Z. 
500 |a 2590-1613 
500 |a 10.1016/j.eurox.2024.100285 
520 |a Objectives: To investigate the feasibility, safety, and efficiency after application of a cervical tourniquet during caesarian hysterectomy owing to placenta accreta Study design: It was a monocentric prospective observational study for 3 years. Patients were allocated into two group: Group Tourniquet: (TG) in which a cervical tourniquet was systematically applied during hysterectomy, control group (CG) when the caesarian hysterectomy was performed without. Results: 20 patients in the TG and 23 patients in the CG. Tourniquet application significantly reduced per operative estimated blood loss volume (TG: 530 ± 135 vs 940 ± 120 ml in the CG, p = 0.0074), ΔHB (0.6 [0.3-1.9] vs 2.5[2.5-3.6] g/dl in the CG, p = 0.006) RBC transfusion requirements' (TG: 2 ± 1.7 vs 4.3 ± 2.1 units in the CG, p = 0.046) procedure duration (TG: 98 ± 21 vs 137 ± 33 min in the CG, p = 0.015), clotting disorders (TG: 1 (5%) vs 6 (26,1%) in the CG, p = 0.013) and the incidence of bladder wounds (TG: 1 (5%) vs 5 (21,7%) in the CG, p = 0.048). There was no significant difference regarding ICU transfer rate (TG: 16 (80%) vs 20 (86.9%) in the CG, p = 0.53) or length of stay (TG: 1.4 [2,3] vs 2.3 [1-4] days in the CG, p = 0.615) and digestive wound (TG: 0 vs 2 (8,7%) in the CG, p = 0.641). Conclusion: In case of a radical management of placenta accreta. A strategy that involves the application of a cervical Tourniquet should be considered as a feasible, safe and above all efficient alternative to prevent blood spoliation. 
546 |a EN 
690 |a Blood loss 
690 |a Hemoglobin variation 
690 |a Maternal morbidity 
690 |a Placenta accreta 
690 |a Postpartum hemorrhage 
690 |a Tourniquet 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 21, Iss , Pp 100285- (2024) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S259016132400005X 
787 0 |n https://doaj.org/toc/2590-1613 
856 4 1 |u https://doaj.org/article/ba86016bc2bd41ed8f65cf3d71b22de4  |z Connect to this object online.